Objectives This study aims to (1) evaluate the probability and timing of termination of
pregnancy for fetal anomaly (TOPFA) for all congenital heart defects (CHD) and categories …

Newborn screening for critical congenital heart defects, added in September 2011 to the
Recommended Uniform Screening Panel in the United States, is a new public health priority …

Background Our objective was to estimate receipt of preconception health care among
women with congenital heart defects (CHD), according to 2017 American Heart Association …

Objective Fetuses with congenital heart disease (CHD) are at increased risk of pregnancy
loss compared with the general population. We aimed to assess the incidence, timing and …

Critical congenital heart defects (CCHD) occur in approximately two of every 1,000 live
births (1). Newborn screening provides an opportunity for reducing infant morbidity and …

Objective To examine state-wide population trends in preterm delivery of children with
critical congenital heart disease (CHD) over an 18-year period. We hypothesized that …

Aim: To study the development and effectiveness of prenatal diagnostics for congenital heart
defects (CHDs). To monitor the overall incidence of CHDs and the level of detection for …

Objective: The objective of this study is to assess the delivery outcomes of neonates with
congenital heart defects (CHD), and to explore the effect of prenatal diagnosis on these …

Objective Congenital heart disease (CHD) is the most common congenital malformation and
causes major morbidity and mortality. Prenatal detection improves the neonatal condition …

Antenatal screening for fetal cardiac abnormalities was introduced over 25 years ago, yet
detection of congenital heart disease before birth remains a challenge. While experienced …